Oct 5 Shield Therapeutics Plc (IPO-SHIE.L)
• Shield Therapeutics postpones its initial public offering due to unfavourable market conditions
• Recent increase in volatility currently does not allow co to launch IPO and achieve smooth transition to public markets Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)
Help employers find you! Check out all the jobs and post your resume.
